Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Combination Details

General Information of the Combination (ID: C50594)
Name Anisodamine   NP Info  + Neostigmine   Drug Info 
Structure +
Disease
Rheumatoid arthritis [ICD-11: FA20]
Investigative [1]
Ischemic stroke [ICD-11: 8B11]
Investigative [2]
Lethal crush syndrome [ICD-11: NF0A]
Investigative [3]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [2]
                    Molecule(s)
                    Regulation
Down-regulation Expression BAD  Molecule Info 
Pathway MAP
Down-regulation Expression BAX  Molecule Info 
Pathway MAP
                    In-vivo Model Male Sprague-Dawley rats were used in this study.
                    Experimental
                    Result(s)
Current study identified the optimal combination of neostigmine and anisodamine against ischemic stroke, and indicated that the acetylcholine-Alpha7 nicotinic acetylcholine receptor is involved in the protective effects.
                    Experiment 2 Reporting the Effect of This Combination [3]
                    Molecule(s)
                    Regulation
Up-regulation Expression JAK-2  Molecule Info 
Pathway MAP
Up-regulation Expression STAT3  Molecule Info 
Pathway MAP
                    In-vivo Model SD rats (250-270 g), C57BL/6 mice (25-30 g), and rabbits (2-3 kg) CS models were used in this study.
                    Experimental
                    Result(s)
Ani/Neo combination could produce therapeutic effects in CS.
                    Experiment 3 Reporting the Effect of This Combination [1]
                    In-vivo Model CIA was induced in DBA/1 mice which were immunized with 100 ug bovine type II collagen and emulsified with an equal volume of complete Freund's adjuvant.
                    Experimental
                    Result(s)
A combination of anisodamine and neostigmine could decrease arthritic index, reduce joint swelling, and inhibit weight loss.
References
Reference 1 Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen-induced arthritis mice. CNS Neurosci Ther. 2014 Feb;20(2):186-7.
Reference 2 A combination of neostigmine and anisodamine protects against ischemic stroke by activating Alpha7nAChR. Int J Stroke. 2015 Jul;10(5):737-44.
Reference 3 Combined administration of anisodamine and neostigmine rescued acute lethal crush syndrome through Alpha7nAChR-dependent JAK2-STAT3 signaling. Sci Rep. 2016 Nov 22;6:37709.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China